Maldi imaging 25 Years Maldi web
MALDI Innovations in Pharma

MALDI Innovations in Pharma

February 21/22, 2018 in Mannheim, Germany


Building on 25 years of excellence in MALDI mass spectrometry, Bruker has developed a new set of technologies that are impacting the pharmacological related industry far beyond the traditional role of quantitation and process monitoring. From lead generation all the way through to pre-clinical assessment, drug companies are employing these advanced MALDI based technologies in a wide range of roles to increase the speed and specificity of hit finding, ADME/tox and PK/PD studies, drug-to-target validation studies, and much more. Come join several industry leaders from top pharma around the globe as they present their perspectives on using these advances to streamline the drug development process.

Seminar Sessions

February 21: rapifleX MALDI PharmaPulse: reset your expectation for label-free high-throughput-screening utilizing mass spectrometry

February 22: MS Imaging Applications in Pharma and Chemical Biology

To participate, please register via the form below.

We look forward to seeing you in Mannheim,

Your Bruker Daltonics Team

For further information, please contact:
Anne Kropp-Schnisa
Bruker Daltonik GmbH
Fahrenheitsstrasse 4
28359 Bremen

Venue Info
Hochschule Mannheim
Aula in building B -
Entrance via building C
Paul-Wittsack-Strasse 10
68163 Mannheim


The registration has been closed. For further details please contact Anne Kropp-Schnisa: